An approach to pleomorphic sarcomas: Can we subclassify, and does it matter?

Modern Pathology

Volumn 27, Issue SUPPL. 1, 2014, Pages

  Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

malignant fibrous histiocytoma; pleomorphic sarcoma; sarcomatoid carcinoma; undifferentiated pleomorphic sarcoma

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CYTOGENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; UNDIFFERENTIATED CARCINOMA; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SARCOMA; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84891675384     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.174     Document Type: Article

References (37)

1. Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963;16:331-344.
2. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964;17:1445-1455.
3. Iwasaki H, Isayama T, Johzaki H, et al. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Am. J. Pathol 1987;128:528-537. (Pubitemid 17139903)
4. Iwasaki H, Isayama T, Ohjimi Y, et al. Malignant fibrous histiocytoma. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer 1992;69:437-447.
5. Roholl PJ, Kleyne J, Elbers H, et al. Characterization of tumour cells in malignant fibrous histiocytomas and other soft tissue tumours in comparison with malignant histiocytes. I. Immunohistochemical study on paraffin sections. J Pathol 1985;147:87-95. (Pubitemid 16199603)
6. Roholl PJ, Kleyne J, Van Unnik JA. Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections. Am J Pathol 1985;121:269-274. (Pubitemid 16230694)
7. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-228.
8. Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 2001;38:499-509. (Pubitemid 32863002)
9. Deyrup AT, Haydon RC, Huo D, et al. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer 2003;98:805-813. (Pubitemid 36959278)
10. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001;19:3045-3050. (Pubitemid 32565442)
11. Massi D, Beltrami G, Capanna R, et al. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol 2004;30:1131-1136. (Pubitemid 40267821)
12. McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 1994;18: 1213-1223. (Pubitemid 24362434)
13. Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997;21: 271-281. (Pubitemid 27120195)
14. Binh MBN, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340-1347. (Pubitemid 41368770)
15. Jo VY. Fletcher CDM. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol 2011;136:762-766.
16. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978;41: 2250-2266. (Pubitemid 8370196)
17. Guccion JG, Enzinger FM. Malignant giant cell tumor of soft parts. An analysis of 32 cases. Cancer 1972;29:1518-1529.
18. van Haelst UJ, de Haas van Dorsser AH. Giant cell tumor of soft parts. An ultrastructural study. Virchows Arch A Pathol Anat Histol 1976;371:199-217.
19. Brecher ME, Franklin WA. Absence of mononuclear phagocyte antigens in malignant fibrous histiocytoma. Am J Clin Pathol 1986;86:344-348. (Pubitemid 16023562)
20. Wood GS, Beckstead JH, Turner RR, et al. Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 1986;10:323-335. (Pubitemid 16038743)
21. Agaimy A, Gaumann A, Schroeder J, et al. Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation. Virchows Arch 2007;451:949-957. (Pubitemid 350060741)
22. Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987;11:375-383. (Pubitemid 17058903)
23. Litzky LA, Brooks JJ. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffinembedded tissues. Mod Pathol 1992;5:30-34.
24. Weiss SW, Bratthauer GL, Morris PA. Postirradiation malignant fibrous histiocytoma expressing cytokeratin. Implications for the immunodiagnosis of sarcomas. Am J Surg Pathol 1988;12:554-558.
25. Gazziola C, Cordani N, Wasserman B, et al. Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. Int J Oncol 2003;23:343-351.
26. Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med 2008;132:1030-1035. (Pubitemid 351918713)
27. Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer 1998;22: 16-25. (Pubitemid 28217802)
28. Kageyama K, Moriyama T, Hizuka N, et al. Hypoglycemia associated with big insulin-like growth factor II produced during development of malignant fibrous histiocytoma. Endocr J 2003;50:753-758. (Pubitemid 38139961)
29. Larramendy ML, Gentile M, Soloneski S, et al. Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma Cancer Genet Cytogenet 2008;187:1-11.
30. Nishio J, Iwasaki H, Nabeshima K, et al. Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization. J Exp Clin Cancer Res 2010;29:153.
31. Carneiro A, Francis P, Bendahl P-O, et al. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin Lab Invest 2009;89:668-675.
32. Engellau J, Anderson H, Rydholm A, et al. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer 2004;100:2233-2239. (Pubitemid 38580345)
33. Le Doussal V, Coindre JM, Leroux A, et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 1996;77: 1823-1830. (Pubitemid 26125182)
34. Salo JC, Lewis JJ, Woodruff JM, et al. Malignant fibrous histiocytoma of the extremity. Cancer 1999;85: 1765-1772. (Pubitemid 29169678)
35. Gibbs JF, Huang PP, Lee RJ, et al. Malignant fibrous histiocytoma: an institutional review. Cancer Invest 2001;19:23-27. (Pubitemid 32233798)
36. Zagars GK, Mullen JR, Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1996;34:983-994. (Pubitemid 26105436)
37. Belal A, Kandil A, Allam A, et al. Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 2002;25:16-22. (Pubitemid 34131022)